A comparative study of Watson for Oncology and tumor boards in breast cancer treatment

Dohoon Kim; Yun Young Kim; Joon-Hyop Lee; Yoo Seung Chung; Sangtae Choi; Jin Mo Kang; Heung Kyu Park; Yong Soon Chun

추천

검색

질문

자료유형: 학술저널

저자정보: Dohoon Kim (Gachon University Gil Medical Center) Yun Young Kim (Gachon University Gil Medical Center) Joon-Hyop Lee (Gachon University Gil Medical Center) Yoo Seung Chung (Gachon University Gil Medical Center) Sangtae Choi (Gachon University Gil Medical Center) Jin Mo Kang (Gachon University Gil Medical Center) Heung Kyu Park (Gachon University Gil Medical Center) Yong Soon Chun (Gachon University Gil Medical Center)

저널정보: 대한종양외과학회 KOREAN JOURNAL OF CLINICAL ONCOLOGY Korean Journal of Clinical Oncology 제15권 제1호

발행연도: 2019.6

수록면: 3 - 6 (4page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Purpose: Watson for Oncology (WFO) is a computing system for considering treatment option with patients. The aim of this study is to determine the concordance rate of WFO and tumor board in treatment options of breast cancer.
Methods: One hundred and seventy breast cancer patients who were treated at Gachon University Gil Medical Center (GMC) from December 2016 to March 2018 were investigated. “Concordance” is defined that treatment provided by GMC tumor board and WFO-provided treatments (Recommend or For Consideration) were coincide. “Discordance” is defined that treatment provided by GMC tumor board and WFO-provided treatments (Not Recommended or Not Available) were coincide.
Results: In chemotherapy, of the total 170 patients, 23 patients were excluded, and the concordance rate was compared in 147 patients. Concordance rate was 93% (136/147). In the 11 patients who were discordant, seven patients complied with the treatment proposed by GMC tumor board due to insurance problems and age, and two patients did not follow the treatment proposed by WFO due to pregnancy and patient’s choice, and one patient chose a treatment determined by WFO, last one patient was not treated with chemotherapy because it was not considered to be clinically necessary. In radiotherapy, the overall agreement rate was as high as 99% (147/148).
Conclusion: Through this study, we found that many of the treatment proposals provided by WFO are highly reliable. Although the overall agreement is high in the radiotherapy regimen, the indication for radiotherapy by WFO is more aggressive and hypofractionated high dose intensity radiotherapy is growing trend by WFO.

#Watson for Oncology #Breast neoplasms #Treatment option #Concordance #Tumor board

참고문헌 (8)

참고문헌 신청

National Institutes of Health / Drugs approved for breast cancer

Taichman DB / 2016 / Sharing clinical trial data: a proposal from the international committee of medical journal editors / Ann Intern Med 164:505~506

Taichman DB / 2016 / Sharing clinical trial data: a proposal from the international committee of medical journal editors / N Engl J Med 374:384~386

Duda RO / 1983 / Expert systems research / Science 220:261~268

Somashekhar SP / 2018 / Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board / Ann Oncol 29:418~423

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!